News & Blog

What the Brain Tumor Community Was Reading in 2019

Below are the “Top 10” most-read blogs and news stories from the NBTS website over the course of 2019. Included are recaps of the inspiring moments in the brain tumor community, promising updates on advances we’re making together, and powerful testimonials from patients and families impacted by brain tumors. 1. Glioblastoma Awareness Day Resolution Passes […]

NBTS Brain Tumor Clinical Trials Report – October 2019

Brain tumor clinical trials open around the country all the time, and it can be hard for patients and care partners to keep track of new opportunities to consider participation in leading-edge clinical research. This report, generated by the National Brain Tumor Society, provides a summary of clinical trials that have started or begun recruitment […]

Can Newly Approved “Tissue Agnostic” Drugs Benefit Pediatric High-grade Glioma Patients?

Recently, the U.S. Food and Drug Administration (FDA) granted accelerated approval* to the drug Rozlytrek (entrectinib, Genentech/Roche**) as a treatment for patients, 12 years or older, whose tumors have a specific genetic defect known as an “NTRK gene fusion.”*** This is now the second drug that the FDA has approved to treat patients with this […]

Share